Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olanzapine in the Treatment of Patients With Anorexia Nervosa

This study has been completed.
Eli Lilly and Company
Information provided by:
Ottawa Hospital Research Institute Identifier:
First received: November 30, 2005
Last updated: September 30, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):